Reactions 1421 - 29 Sep 2012

★ SPregabalin

First report of haemorrhagic vasculitis: casereport

A study identified a 21-year-old woman who developedhaemorrhagic vasculitis during adjunctive treatment withpregabalin [Lyrica] for temporal epilepsy. Pregabalin hadbeen initiated at 75mg twice daily and, after 1.5 years, shepresented with a haemorrhagic rash on her legs which wasdetermined to be haemorrhagic vasculitis [dosage atreaction onset not stated]. Pregabalin was switched toNeurontin [outcome not stated].

Author comment: "Efficacy and tolerability of a newantiepileptic drug pregabalin (Lyrica) as an add-on drug inpatients with focal refractory epilepsy wasanalyzed. . . hemorrhagic vasculitis was registered in onepatient."Vlasov PN, et al. Lyrica (pregabalin) in the treatment of focal refractory epilepsyin adults. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110: 53-9, No. 12,2010 [Russian; summarised from a translation] - Russia 803077961

» Editorial comment: A search of AdisBase, Medline,Embase and the WHO ADR database did not reveal anyprevious case reports of hemorrhagic vasculitis associatedwith pregabalin.

1

Reactions 29 Sep 2012 No. 14210114-9954/10/1421-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved